PNC Financial Services Group Inc. decreased its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL) by 16.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 42,294 shares of the company’s stock after selling 8,450 shares during the period. PNC Financial Services Group Inc.’s holdings in Omnicell were worth $3,043,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of OMCL. Bank of Montreal Can purchased a new stake in Omnicell during the second quarter valued at about $102,000. Stone Ridge Asset Management LLC purchased a new stake in Omnicell during the third quarter valued at about $202,000. Everence Capital Management Inc. purchased a new stake in Omnicell during the third quarter valued at about $204,000. Evanston Investments Inc. dba Evanston Advisors purchased a new stake in Omnicell during the third quarter valued at about $216,000. Finally, First Republic Investment Management Inc. purchased a new stake in Omnicell during the second quarter valued at about $226,000.
A number of equities research analysts have weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and set a $80.00 price target (up previously from $70.00) on shares of Omnicell in a research report on Thursday. Zacks Investment Research restated a “strong-buy” rating and set a $78.00 price target on shares of Omnicell in a research report on Wednesday, November 14th. BidaskClub upgraded Omnicell from a “buy” rating to a “strong-buy” rating in a research report on Thursday, November 22nd. Oppenheimer lifted their price objective on Omnicell from $71.00 to $73.00 and gave the stock an “outperform” rating in a report on Friday, October 26th. Finally, Wells Fargo & Co lifted their price objective on Omnicell from $59.00 to $61.00 and gave the stock a “market perform” rating in a report on Monday, October 29th. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $72.13.
OMCL opened at $69.83 on Friday. The stock has a market capitalization of $2.80 billion, a PE ratio of 387.94, a P/E/G ratio of 4.22 and a beta of 0.99. The company has a current ratio of 1.78, a quick ratio of 1.32 and a debt-to-equity ratio of 0.27. Omnicell, Inc. has a 12 month low of $39.75 and a 12 month high of $79.48.
Omnicell (NASDAQ:OMCL) last released its quarterly earnings data on Thursday, October 25th. The company reported $0.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.40 by $0.09. The firm had revenue of $204.27 million for the quarter, compared to the consensus estimate of $203.48 million. Omnicell had a return on equity of 7.91% and a net margin of 6.11%. On average, analysts predict that Omnicell, Inc. will post 1.42 earnings per share for the current year.
In other news, EVP Dan S. Johnston sold 6,250 shares of Omnicell stock in a transaction dated Monday, October 15th. The stock was sold at an average price of $63.47, for a total value of $396,687.50. Following the transaction, the executive vice president now owns 35,996 shares in the company, valued at $2,284,666.12. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Peter J. Kuipers sold 5,574 shares of Omnicell stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $68.87, for a total value of $383,881.38. Following the completion of the transaction, the chief financial officer now owns 51,542 shares in the company, valued at approximately $3,549,697.54. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,267 shares of company stock worth $1,309,116. Company insiders own 3.71% of the company’s stock.
WARNING: “Omnicell, Inc. (OMCL) Shares Sold by PNC Financial Services Group Inc.” was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.thelincolnianonline.com/2018/12/08/omnicell-inc-omcl-shares-sold-by-pnc-financial-services-group-inc.html.
Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.
Featured Article: What is a Stop Order?
Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.